Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential σ Receptor Marker for Human Prostate Tumors

This publication has 9 references indexed in Scilit:

• Sigma receptors are expressed in human non-small cell lung carcinoma
  Life Sciences, 1995
• Radioimmunoscintigraphy of Pelvic Lymph Nodes with¹¹¹Indium-Labeled Monoclonal Antibody CYT-356
  Journal of Urology, 1994
• Radioimmunoscintigraphy with¹¹¹Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer Recurrence
  Journal of Urology, 1994
• Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Synthesis and Characterization of [125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide, a New .sigma. Receptor Radiopharmaceutical: High-Affinity Binding to MCF-7 Breast Tumor Cells
  Journal of Medicinal Chemistry, 1994
• A proposal for the classification of sigma binding sites
  Trends in Pharmacological Sciences, 1992
• A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain
  Brain Research, 1990
• σ-Receptors in Endocrine Organs: Identification, Characterization, and Autoradiographic Localization in Rat Pituitary, Adrenal, Testis, and Ovary
  Endocrinology, 1989
• 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
  Proceedings of the National Academy of Sciences, 1986